PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy - a study in a Swedish rectal cancer trial of preoperative radiotherapy

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Holmqvist, Annica ^a   Gao, Jingfang ^a   Holmlund, Birgitta ^a   Adell, Gunnar ^a   Carstensen, John ^a   Langford, Dianne ^b   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunohistochemistry; Pinch; Prognosis; Radiotherapy; Rectal cancer

Indexed keywords

LIM PROTEIN; PARTICULARLY INTERESTING NEW CYSTEINE HISTIDINE RICH PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; PREOPERATIVE PERIOD; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CANCER; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LIM DOMAIN PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84862807385     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-65     Document Type: Article

References (22)

1. Rearden A. A new LIM protein containing an autoepitope homologous to "senescent cell antigen". Biochem Biophys Res Commun 1994, 201:1124-1131. 10.1006/bbrc.1994.1822, 7517666.
2. Tu Y, Li F, Wu C. Nck-2, a novel scr homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways. Mol Biol Cell 1998, 9:3367-3382. 25640, 9843575.
3. Tu Y, Li F, Goicoechea S, Wu C. The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol 1999, 19:2425-2434. 84035, 10022929.
4. Fukuda T, Chen K, Shi X, Wu C. PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J Biol Chem 2003, 278:51324-51333. 10.1074/jbc.M309122200, 14551191.
5. Guo L, Wu C. Regulation of fibronectin matrix deposition and cell proliferation by the PINCH-ILK-CH-ILKBP complex. FASEB J 2002, 16:1298-12300.
6. Wang-Rodriguez J, Dreilinger A, Alsharabi G, Rearden A. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges. Cancer 2002, 95:1387-1395. 10.1002/cncr.10878, 12216108.
7. Gao J, Arbman G, Rearden A, Sun X-F. Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer. Neoplasia 2004, 6:796-801. 10.1593/neo.04304, 1531683, 15720806.
8. Zhu Z, Yang Y, Zhang Y, Wang Z, Cui D, Zhang J, Wang M, Sun XF. PINCH expression and its significance in esophageal squamous cell carcinoma. Dis Markers 2008, 25:75-80.
9. Wang MW, Gu P, Zhang ZY, Zhu ZL, Li YM, Zhao HX, Sun XF. Expression of PINCH protein in gliomas and its clicopathological significance. Oncology 2007, 72:343-346. 10.1159/000113064, 18187956.
10. Eke I, Koch U, Hehlgans S, Sandfort V, Stanchi F, Zips D, Baumann M, Shevchenko A, Pilarsky C, Haase M, Baretton G, Calleja V, Larijani B, Fässler R, Cordes N. PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1α. J Clin Invest 2010, 120:2516-2527. 10.1172/JCI41078, 2898588, 20530873.
11. Sandfort V, Eke I, Cordes N. The role of focal adhesion protein PINCH1 for the radiosensitivity of adhesion and suspension cell cultures. PLoS One 2010, 5:e13056.
12. Chen K, Tu Y, Zhang Y, Blair H, Zhang L, Wu C. PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells. J Biol Chem 2008, 283:2508-2517.
13. Påhlman L. Improved survival with preoperative radiotherapy in resectable cancer. N Engl J Med 1997, 336:980-987.
14. Holmqvist A, Gao J, Adell G, Carstensen J, Sun X-F. The location of lymphangiogenesis is an independent prognostic factor in rectal cancer patients with or without radiotherapy. Ann Oncol 2010, 21:512-517. 10.1093/annonc/mdp486, 19889620.
15. Knutsen A, Adell G, Sun X-F. Inflammatory infiltration, fibrosis, necrosis and mucinous content in relation to clinicopathological and molecular factors in rectal cancers with or without preoperative radiotherapy. Oncol Rep 2006, 16:321-327.
16. Adell GC, Zang H, Evertsson S, Sun X-F, Stål O, Nordenskjöld B. Apoptosis in rectal cancer: Prognosis and recurrence after preoperative radiotherapy. Cancer 2001, 91:1870-1875. 10.1002/1097-0142(20010515)91:10<1870::AID-CNCR1208>3.0.CO;2-1, 11346868.
17. Farnebo L, Jerhammar F, Vainikka L, Grenman R, Norberg-Spaak L, Roberg K. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines. Oncol Rep 2008, 20:453-461.
18. Schmidt-Ullrich RK, Valerie KC, Chan W, McWilliams D. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int J Radiat Oncol Biol Phys 1994, 29:813-819. 10.1016/0360-3016(94)90570-3, 8040028.
19. Ruifrok AC, Mason KA, Lozano G, Thames HD. Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment. Radiat Res 1997, 147:1-12. 10.2307/3579436, 8989363.
20. Jackowski S, Janusch M, Fiedler E, Marsch WC, Ulbrich EJ, Gaisbauer G, Dunst J, Kerjaschki D, Helmbold P. Radiogenic lymphangiogenesis in the skin. Am J Pathol 2007, 171:338-345. 10.2353/ajpath.2007.060589, 1941592, 17591978.
21. Lammering G, Taher MM, Gruenagel HH, Borchard F, Porschen R. Alterations in DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer. Clin Cancer Res 2000, 6:3215-3221.
22. Van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ, . Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011, 12:575-82. 10.1016/S1470-2045(11)70097-3, 21596621, Dutch Colorectal Cancer Group.